Literature DB >> 27596958

Induced pluripotent stem cell - derived neurons for the study of spinocerebellar ataxia type 3.

Susanne K Hansen1, Tina C Stummann2, Helena Borland2, Lis F Hasholt3, Zeynep Tümer4, Jørgen E Nielsen5, Mikkel A Rasmussen6, Troels T Nielsen7, Justus C A Daechsel2, Karina Fog2, Poul Hyttel6.   

Abstract

The neurodegenerative disease spinocerebellar ataxia type 3 (SCA3) is caused by a CAG-repeat expansion in the ATXN3 gene. In this study, induced pluripotent stem cell (iPSC) lines were established from two SCA3 patients. Dermal fibroblasts were reprogrammed using an integration-free method and the resulting SCA3 iPSCs were differentiated into neurons. These neuronal lines harbored the disease causing mutation, expressed comparable levels of several neuronal markers and responded to the neurotransmitters, glutamate/glycine, GABA and acetylcholine. Additionally, all neuronal cultures formed networks displaying synchronized spontaneous calcium oscillations within 28days of maturation, and expressed the mature neuronal markers NeuN and Synapsin 1 implying a relatively advanced state of maturity, although not comparable to that of the adult human brain. Interestingly, we were not able to recapitulate the glutamate-induced ataxin-3 aggregation shown in a previously published iPSC-derived SCA3 model. In conclusion, we have generated a panel of SCA3 patient iPSCs and a robust protocol to derive neurons of relatively advanced maturity, which could potentially be valuable for the study of SCA3 disease mechanisms.
Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27596958     DOI: 10.1016/j.scr.2016.07.004

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  9 in total

1.  Antisense oligonucleotide therapy rescues aggresome formation in a novel spinocerebellar ataxia type 3 human embryonic stem cell line.

Authors:  Lauren R Moore; Laura Keller; David D Bushart; Rodrigo G Delatorre; Duojia Li; Hayley S McLoughlin; Maria do Carmo Costa; Vikram G Shakkottai; Gary D Smith; Henry L Paulson
Journal:  Stem Cell Res       Date:  2019-07-16       Impact factor: 2.020

Review 2.  Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells.

Authors:  Swati Naphade; Kizito-Tshitoko Tshilenge; Lisa M Ellerby
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

Review 3.  Mutant Ataxin-3-Containing Aggregates (MATAGGs) in Spinocerebellar Ataxia Type 3: Dynamics of the Disorder.

Authors:  Kritika Raj; Ravi Shankar Akundi
Journal:  Mol Neurobiol       Date:  2021-02-24       Impact factor: 5.590

4.  Pueraria lobata and Daidzein Reduce Cytotoxicity by Enhancing Ubiquitin-Proteasome System Function in SCA3-iPSC-Derived Neurons.

Authors:  I-Cheng Chen; Kuo-Hsuan Chang; Yi-Jing Chen; Yi-Chun Chen; Guey-Jen Lee-Chen; Chiung-Mei Chen
Journal:  Oxid Med Cell Longev       Date:  2019-10-07       Impact factor: 6.543

5.  Stiff-to-Soft Transition from Glass to 3D Hydrogel Substrates in Neuronal Cell Culture.

Authors:  Gulden Akcay; Regina Luttge
Journal:  Micromachines (Basel)       Date:  2021-02-08       Impact factor: 2.891

6.  Allele-specific targeting of mutant ataxin-3 by antisense oligonucleotides in SCA3-iPSC-derived neurons.

Authors:  Stefan Hauser; Jacob Helm; Melanie Kraft; Milena Korneck; Jeannette Hübener-Schmid; Ludger Schöls
Journal:  Mol Ther Nucleic Acids       Date:  2021-11-19       Impact factor: 8.886

7.  Nuclear inclusions of pathogenic ataxin-1 induce oxidative stress and perturb the protein synthesis machinery.

Authors:  Stamatia Laidou; Gregorio Alanis-Lobato; Jan Pribyl; Tamás Raskó; Boris Tichy; Kamil Mikulasek; Maria Tsagiopoulou; Jan Oppelt; Georgia Kastrinaki; Maria Lefaki; Manvendra Singh; Annika Zink; Niki Chondrogianni; Fotis Psomopoulos; Alessandro Prigione; Zoltán Ivics; Sarka Pospisilova; Petr Skladal; Zsuzsanna Izsvák; Miguel A Andrade-Navarro; Spyros Petrakis
Journal:  Redox Biol       Date:  2020-02-11       Impact factor: 11.799

Review 8.  Patient-Specific iPSCs-Based Models of Neurodegenerative Diseases: Focus on Aberrant Calcium Signaling.

Authors:  Dmitriy A Grekhnev; Elena V Kaznacheyeva; Vladimir A Vigont
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

Review 9.  Human Induced Pluripotent Stem Cell-Based Modelling of Spinocerebellar Ataxias.

Authors:  Bart P C van de Warrenburg; Hans van Bokhoven; Marina P Hommersom; Ronald A M Buijsen; Willeke M C van Roon-Mom
Journal:  Stem Cell Rev Rep       Date:  2021-05-25       Impact factor: 5.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.